These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
307 related items for PubMed ID: 22658882
1. Prognostic significance of primary Gleason pattern in Japanese men with Gleason score 7 prostate cancer treated with radical prostatectomy. Miyake H, Muramaki M, Furukawa J, Tanaka H, Inoue TA, Fujisawa M. Urol Oncol; 2013 Nov; 31(8):1511-6. PubMed ID: 22658882 [Abstract] [Full Text] [Related]
2. Outcome after radical prostatectomy with a pretreatment prostate biopsy Gleason score of >/=8. Manoharan M, Bird VG, Kim SS, Civantos F, Soloway MS. BJU Int; 2003 Oct; 92(6):539-44. PubMed ID: 14511029 [Abstract] [Full Text] [Related]
8. Impact of positive surgical margins on prostate-specific antigen failure after radical prostatectomy in adjuvant treatment-naïve patients. Ploussard G, Agamy MA, Alenda O, Allory Y, Mouracade P, Vordos D, Hoznek A, Abbou CC, de la Taille A, Salomon L. BJU Int; 2011 Jun; 107(11):1748-54. PubMed ID: 20883488 [Abstract] [Full Text] [Related]
9. Gleason grade grouping of prostate cancer is of prognostic value in Asian men. Yeong J, Sultana R, Teo J, Huang HH, Yuen J, Tan PH, Khor LY. J Clin Pathol; 2017 Sep; 70(9):745-753. PubMed ID: 28289065 [Abstract] [Full Text] [Related]
10. Prognostic significance of percentage Gleason grade 5 prostatic adenocarcinoma in needle biopsies from patients treated by radical prostatectomy. Yaxley W, Delahunt B, Yaxley J, Thunders MC, Kenwright DN, Egevad L, Samaratunga H. Pathology; 2022 Oct; 54(6):694-699. PubMed ID: 35613972 [Abstract] [Full Text] [Related]
11. Improved risk stratification for biochemical recurrence after radical prostatectomy using a novel risk group system based on prostate specific antigen density and biopsy Gleason score. Freedland SJ, Wieder JA, Jack GS, Dorey F, deKernion JB, Aronson WJ. J Urol; 2002 Jul; 168(1):110-5. PubMed ID: 12050502 [Abstract] [Full Text] [Related]
12. Seminal vesicle involvement after radical prostatectomy: predicting risk factors for progression. Salomon L, Anastasiadis AG, Johnson CW, McKiernan JM, Goluboff ET, Abbou CC, Olsson CA, Benson MC. Urology; 2003 Aug; 62(2):304-9. PubMed ID: 12893340 [Abstract] [Full Text] [Related]
15. The significance of micro-lymphatic invasion and pathological Gleason score in prostate cancer patients with pathologically organ-confined disease and negative surgical margins after robot-assisted radical prostatectomy. Hashimoto T, Nakashima J, Inoue R, Komori O, Yamaguchi Y, Kashima T, Satake N, Nakagami Y, Namiki K, Nagao T, Ohno Y. Int J Clin Oncol; 2020 Feb; 25(2):377-383. PubMed ID: 31673831 [Abstract] [Full Text] [Related]
16. Prediction of biochemical recurrence after robot-assisted radical prostatectomy: analysis of 784 Japanese patients. Hashimoto T, Yoshioka K, Nagao G, Nakagami Y, Ohno Y, Horiguchi Y, Namiki K, Nakashima J, Tachibana M. Int J Urol; 2015 Feb; 22(2):188-93. PubMed ID: 25339062 [Abstract] [Full Text] [Related]
17. Race as an outcome predictor after radical prostatectomy: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database. Freedland SJ, Amling CL, Dorey F, Kane CJ, Presti JC, Terris MK, Aronson WJ, Shared Equal Access Regional Cancer Hospital Database Study Group. Urology; 2002 Oct; 60(4):670-4. PubMed ID: 12385931 [Abstract] [Full Text] [Related]
19. Prognostic significance of the presence of tertiary Gleason grade 5 in robot-assisted radical prostatectomy specimens in Japanese patients with clinically localized prostate cancer. Kamoda N, Ohori M, Hirasawa Y, Inoue R, Hashimoto T, Satake N, Gondo T, Nakagami Y, Nagao T, Ohno Y. Jpn J Clin Oncol; 2019 Mar 01; 49(3):276-280. PubMed ID: 30649377 [Abstract] [Full Text] [Related]